747123
Last Update Posted: 2024-10-03
Recruiting has ended
All Genders accepted | 18 Years + |
30 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma
Multi-center, randomized, multiple-dose study to evaluate the safety, tolerability and efficacy of ACE-011 in patients with osteolytic lesions of multiple myeloma.
Eligibility
Relevant conditions:
Multiple Myeloma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov